US Patent 11352442 Heterodimeric antibodies that bind CD3 and CD38
Patent 11352442 was granted and assigned to Xencor on June, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11352442 Heterodimeric antibodies that bind CD3 and CD38
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
